About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Heterogeneity and Development of Early COPD | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT06096285

Heterogeneity and Development of Early COPD

This study aims to investigate the clinical characteristics and heterogeneities of early chronic obstructive pulmonary disease (COPD), to determine the disease development of early COPD, and to establ...

Lead sponsor: China-Japan Friendship Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Jieping Lei, Ph.D.

CONTACT

+86 010 8420 6408 jiepinglei@126.com

Sponsors

Lead Sponsor

China-Japan Friendship Hospital

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•The individuals who meet the defining criteria of PRISm, COPD Stage 0, Pre-COPD, Early COPD, Young COPD, and Mild COPD, according to the latest GOLD documents and publications.

Exclusion Criteria

•Age \< 18 years or \> 80 years;
•Pregnant or maternal women;
•Having malignant and active tumor(s), and receiving treatment;
•Undergoing a surgical operation;
•Having problems with mental awareness;
•Having difficulties in daily activities;
•Participating in other interventional clinical trials.

Related studies

CLEAR Model for Predicting Ventilatory Liberation in Severe COPD

NCT07579052 · Chronic Obstructive Pulmonary Disease

Pulmonary Rehabilitation for Rural Patients With COPD

NCT06847061 · Chronic Obstructive Pulmonary Disease (COPD

RECRUITINGPhase 2

Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD

NCT05061368 · Chronic Obstructive Pulmonary Disease

RECRUITINGPhase 1/2

Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 · Obesity, Interstitial Lung Disease, and more

RECRUITINGPhase 3

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

NCT07190209 · Chronic Obstructive Pulmonary Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 24, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment84

Start dateFeb 2023

Last updatedOct 24, 2023

Condition

Chronic Obstructive Pulmonary Disease

Locations shown

China-Japan Friendship Hospital

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 24, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions